Dr. Goodpaster is the Scientific Director and a Senior Investigator at the AdventHealth Translational Research Institute. Dr. Goodpaster’s primary research is in the pathophysiology of obesity, insulin resistance, diabetes, and aging, and to help decipher biological mechanisms underlying the health benefits of weight loss and exercise. He has received a number of awards and honors for his work, including the Nathan Shock Award from the National Institute of Aging in 2008, for his work investigating the role of muscle fat infiltration in aging and muscle quality. He is particularly well known for “the athlete’s paradox” which has shifted the paradigm in Type 2 diabetes research to investigate, how and why does fat accumulation in muscle cause insulin resistance in some subjects but not others? 



Dr. Goodpaster has published over 300 peer-reviewed papers, review articles and book chapters. He currently serves as a PI on the NIH-funded Molecular Transducers of Physical Activity Consortium (MoTrPAC) and the Study of Muscle, Mobility and Aging (SOMMA). He has also served on several NIH grant review panels. He has served on Editorial Board for Diabetes and the Journals of Gerontology and served as Associate Editor for both Obesity and Diabetologia. Dr. Goodpaster obtained a B.S. in Biology from Purdue, and after completing a Pre-doctoral Fellowship at Maastricht University in the Netherlands, received his Ph.D. in Human Bioenergetics from Ball State University in 1995.



Expertise terms: Exercise, Obesity, Aging, Metabolic flexibility, Insulin Resistance, Translational metabolism, Clinical exercise interventions, Skeletal muscle lipid metabolism, Mitochondrial energetics